Literature DB >> 642827

Effect of fasting on free and esterified carnitine levels in human serum and urine: correlation with serum levels of free fatty acids and beta-hydroxybutyrate.

J Frohlich, D W Seccombe, P Hahn, P Dodek, I Hynie.   

Abstract

Serum levels of free L-carnitine, acylcarnitines, creatinine, beta-hydroxybutyrate, free fatty acids, cholesterol, triglycerides, and glucose were determined in healthy volunteers during a 24-36-hr fast. The effect of oral administration of free L-carnitine (1 g/person) on these parameters was studied. Urinary excretion of carnitine and creatinine was monitored throughout. Serum and urine levels of free carnitine and its renal clearance decreased during the fast. However, the serum concentration and urinary excretion of acylcarnitines increased during the same interval. Following the ingestion of free L-carnitine, both serum and urinary levels of free L-carnitine rose. Within 6 hr of ingestion, 10% of the administered dose could be accounted for by urinary excretion. No significant effect on the other serum constituents under study was seen following the oral L-carnitine dose. A significant negative correlation was found between serum levels of free L-carnitine and beta-hydroxybutyrate and free fatty acids (r equal -0.567, p less than 0.001 and r equal -0.607, p less than 0.001, respectively) during the fast.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 642827     DOI: 10.1016/0026-0495(78)90022-7

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  25 in total

1.  Impaired fasting tolerance among Alaska native children with a common carnitine palmitoyltransferase 1A sequence variant.

Authors:  Melanie B Gillingham; Matthew Hirschfeld; Sarah Lowe; Dietrich Matern; James Shoemaker; William E Lambert; David M Koeller
Journal:  Mol Genet Metab       Date:  2011-06-28       Impact factor: 4.797

2.  Perinatal changes in plasma carnitine levels in 4 species of mammal.

Authors:  P Hahn; D Seccombe; M E Towell
Journal:  Experientia       Date:  1980-12-15

3.  Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes.

Authors:  Ahmed T Ahmed; Siamak MahmoudianDehkordi; Sudeepa Bhattacharyya; Matthias Arnold; Duan Liu; Drew Neavin; M Arthur Moseley; J Will Thompson; Lisa St John Williams; Gregory Louie; Michelle K Skime; Liewei Wang; Patricio Riva-Posse; William M McDonald; William V Bobo; W Edward Craighead; Ranga Krishnan; Richard M Weinshilboum; Boadie W Dunlop; David S Millington; A John Rush; Mark A Frye; Rima Kaddurah-Daouk
Journal:  J Affect Disord       Date:  2019-11-30       Impact factor: 4.839

4.  Relationship between acid-soluble carnitine and coenzyme A pools in vivo.

Authors:  E P Brass; C L Hoppel
Journal:  Biochem J       Date:  1980-09-15       Impact factor: 3.857

5.  Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes. Evidence for alterations in tissue carnitine transport.

Authors:  C J Rebouche; A G Engel
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

Review 6.  l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.

Authors:  K L Goa; R N Brogden
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

7.  Carnitine and physical exercise.

Authors:  O J Heinonen
Journal:  Sports Med       Date:  1996-08       Impact factor: 11.136

8.  Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity.

Authors:  A K Bhuiyan; K Bartlett; H S Sherratt; L Agius
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

9.  Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects.

Authors:  P Harper; C E Elwin; G Cederblad
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

10.  Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome.

Authors:  W A Gahl; I Bernardini; M Dalakas; W B Rizzo; G S Harper; J M Hoeg; O Hurko; J Bernar
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.